Search Results - "PICCHIO, Gaston"

Refine Results
  1. 1
  2. 2
  3. 3

    TMC278, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI), Active against Wild-Type and NNRTI-Resistant HIV-1 by AZIJN, Hilde, TIRRY, Ilse, VINGERHOETS, Johan, DE BETHUNE, Marie-Pierre, KRAUS, Guenter, BOVEN, Katia, JOCHMANS, Dirk, VAN CRAENENBROECK, Elke, PICCHIO, Gaston, RIMSKY, Laurence T

    Published in Antimicrobial Agents and Chemotherapy (01-02-2010)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase on Phenotypic Susceptibility and Virologic Response to Etravirine by Tambuyzer, Lotke, Nijs, Steven, Daems, Bjorn, Picchio, Gaston, Vingerhoets, Johan

    “…The contribution of E138 mutations to etravirine resistance was investigated. Amino acids at position E138 after failure with etravirine in DUET were A (n =…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs) by Kieffer, Tara L., Kwong, Ann D., Picchio, Gaston R.

    Published in Journal of antimicrobial chemotherapy (01-02-2010)
    “…Promising results have been observed with an investigational drug class for hepatitis C (HCV), the specifically targeted antiviral therapies for hepatitis C…”
    Get full text
    Journal Article
  8. 8

    Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials by KATLAMA, Christine, HAUBRICH, Richard, WOODFALL, Brian, DE SMEDT, Goedele, LALEZARI, Jacob, LAZZARIN, Adriano, MADRUGA, José V, MOLINA, Jean-Michel, SCHECHTER, Mauro, PEETERS, Monika, PICCHIO, Gaston, VINGERHOETS, Johan

    Published in AIDS (London) (13-11-2009)
    “…To evaluate the efficacy, safety and virologic resistance profile of etravirine (TMC125), a next-generation nonnucleoside reverse transcriptase inhibitor, over…”
    Get full text
    Journal Article Web Resource
  9. 9
  10. 10
  11. 11
  12. 12

    Prevalence in the USA of rilpivirine resistance-associated mutations in clinical samples and effects on phenotypic susceptibility to rilpivirine and etravirine by Picchio, Gaston R, Rimsky, Laurence T, Van Eygen, Veerle, Haddad, Mojgan, Napolitano, Laura A, Vingerhoets, Johan

    Published in Antiviral therapy (01-01-2014)
    “…The prevalence of rilpivirine resistance-associated mutations (RAMs) in the USA, and their effect on phenotypic susceptibility to rilpivirine and etravirine,…”
    Get more information
    Journal Article
  13. 13

    Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection by Sung, Vicky M-H, Shimodaira, Shigetaka, Doughty, Alison L, Picchio, Gaston R, Can, Huong, Yen, T S Benedict, Lindsay, Karen L, Levine, Alexandra M, Lai, Michael M C

    Published in Journal of Virology (01-02-2003)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Resistance profile of darunavir: combined 24-week results from the POWER trials by de Meyer, Sandra, Vangeneugden, Tony, van Baelen, Ben, de Paepe, Els, van Marck, Herwig, Picchio, Gaston, Lefebvre, Eric, de Béthune, Marie-Pierre

    Published in AIDS research and human retroviruses (01-03-2008)
    “…The resistance profile of darunavir (TMC114) in treatment-experienced patients was explored using pooled week 24 data from POWER 1, 2, and 3 at the recommended…”
    Get more information
    Journal Article
  16. 16

    Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial by Benhamou, Yves, Moussalli, Joseph, Ratziu, Vlad, Lebray, Pascal, De Backer, Katrien, De Meyer, Sandra, Ghys, Anne, Luo, Donghan, Picchio, Gaston R., Beumont, Maria

    Published in The Journal of infectious diseases (15-09-2013)
    “…Background. This partially blinded, randomized, phase 2a C210 study evaluated the antiviral activity of telaprevir-based regimens in treatment-naive patients…”
    Get full text
    Journal Article
  17. 17

    Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE by Van Eygen, Veerle, Thys, Kim, Van Hove, Carl, Rimsky, Laurence T., De Meyer, Sandra, Aerssens, Jeroen, Picchio, Gaston, Vingerhoets, Johan

    Published in Journal of medical virology (01-05-2016)
    “…Minority variants (1.0–25.0%) were evaluated by deep sequencing (DS) at baseline and virological failure (VF) in a selection of antiretroviral treatment‐naïve,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20